Altruist Biologics seeks to solidify role in China’s booming biologics sector

In a recent BioProcess International article, Dr. Kaisong Zhou, Chairman and CEO of Altruist Biologics, highlighted our Hangzhou facility’s design to meet global regulatory standards and emphasized how advanced technologies and growing capacity position the company to support global clients, reflecting China’s increasing importance as a hub for high-quality, large-scale biologics manufacturing.